Colistin (Polymyxin E) Injectable Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV/IM/SC)
Available Strengths: 150 mg/5 mL, 300 mg/5 mL, 1.5 million IU/vial
Reference Brands: Coly-Mycin M(US)
Category: Antibiotics
Colistin (Polymyxin E) disrupts bacterial cell membrane integrity by binding to lipopolysaccharides, causing bacterial lysis. It is effective against multidrug-resistant Gram-negative bacteria. Benefits include rapid bactericidal activity, crucial in severe infections like pneumonia and sepsis, especially when other antibiotics fail, making it vital for resistant infection management. Colistin (Polymyxin E) Injectable is available in Injectable (IV/IM/SC) and strengths such as 150 mg/5 mL, 300 mg/5 mL, 1.5 million IU/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Colistin (Polymyxin E) Injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Colistin (Polymyxin E) Injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Colistin (Polymyxin E) is approved in the EU and US for severe, multidrug-resistant Gram-negative bacterial infections. In the EU, brands like Colistin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and safety monitoring. Due to its critical role in combating resistant infections, strict prescribing, storage, and administration regulations are enforced. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We support seamless market access while ensuring adherence to European and US standards.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Tetracycline Hydrochloride
Strength:
250 mg, 500 mg
Form: Tablets, Capsules
Reference Brands: Achromycin (USA)
View DetailsOmadacycline
Strength:
100 mg, 150 mg
Form: Tablet/ Injection
Reference Brands: Nuzyra (USA/EU)
View DetailsNitrofurantoin
Strength:
25 mg, 50 mg, 100 mg
Form: Capsules
Reference Brands: Macrobid (USA), Macrodantin (USA)
View DetailsNafcillin
Strength:
500 mg, 1 g, 2 g
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers